Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification

被引：24
|
作者：
Palma, Norma [1 ]
Morris, John C. [2 ]
Ali, Siraj M. [1 ]
Ross, Jeffrey S. [1 ,3 ]
Pal, Sumanta Kumar [4 ]
机构：
[1] Fdn Med, Cambridge, MA USA
[2] Univ Cincinnati, Inst Canc, Div Hematol Oncol, Cincinnati, OH USA
[3] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA
[4] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA 91010 USA
来源：
EUROPEAN UROLOGY | 2015年 / 68卷 / 01期
关键词：
D O I：
10.1016/j.eururo.2015.02.023
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：168 / 170
页数：4
相关论文
共 50 条
  • [41] Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
    Kim, Young Saing
    Kim, Kyung
    Kwon, Ghee-Young
    Lee, Su Jin
    Park, Se Hoon
    BMC UROLOGY, 2018, 18
  • [42] Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis
    Rizzo, Alessandro
    Mollica, Veronica
    Santoni, Matteo
    Massari, Francesco
    CLINICAL GENITOURINARY CANCER, 2022, 20 (05) : 482 - 487
  • [43] Purine biosynthesis and related enzymes play the oncogenic function in FGFR3 mutant urothelial carcinoma
    Chang, Yu-Chan
    FASEB JOURNAL, 2022, 36
  • [44] FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations
    Lott, Sarah
    Wang, Mingsheng
    Zhang, Shaobo
    MacLennan, Gregory T.
    Lopez-Beltran, Antonio
    Montironi, Rodolfo
    Sung, Ming-Tse
    Tan, Puay-Hoon
    Cheng, Liang
    MODERN PATHOLOGY, 2009, 22 (05) : 627 - 632
  • [45] FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
    Jebar, AH
    Hurst, CD
    Tomlinson, DC
    Johnston, C
    Taylor, CF
    Knowles, MA
    ONCOGENE, 2005, 24 (33) : 5218 - 5225
  • [46] cfDNA is an acceptable but insufficient means of characterizing FGFR3 mutation in patients with metastatic urothelial cancer (mUC)
    Pal, S. K.
    Bajorin, D. F.
    Hoffman-Censits, J. H.
    Quinn, D. I.
    Petrylak, D. P.
    Galsky, M. D.
    Vaishampayan, U. N.
    De Giorgi, U.
    Gupta, S.
    Burris, H. A.
    Soifer, H. S.
    Li, G.
    Dambkowski, C. L.
    Moran, S.
    Wang, H.
    Daneshmand, S.
    Rosenberg, J. E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [47] Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification
    Wang, Xiaomeng
    Cao, Jie
    Du, Weijiao
    Zhang, Weihong
    Cao, Shui
    CLINICAL CASE REPORTS, 2021, 9 (07):
  • [48] Sudden infant death in a patient with FGFR3 P250R mutation
    Shah, P. S.
    Siriwardena, K.
    Taylor, G.
    Steele, L.
    Ray, P.
    Blaser, S.
    Chitayat, D.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (24) : 2794 - 2796
  • [49] Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma
    Al-Ahmadie, Hikmat A.
    Iyer, Gopa
    Janakiraman, Manickam
    Lin, Oscar
    Heguy, Adriana
    Tickoo, Satish K.
    Fine, Samson W.
    Gopalan, Anuradha
    Chen, Ying-bei
    Balar, Arjun
    Riches, Jamie
    Bochner, Bernard
    Dalbagni, Guido
    Bajorin, Dean F.
    Reuter, Victor E.
    Milowsky, Matthew I.
    Solit, David B.
    JOURNAL OF PATHOLOGY, 2011, 224 (02): : 270 - 279
  • [50] Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype
    Weyerer, Veronika
    Eckstein, Markus
    Comperat, Eva
    Juette, Hendrik
    Gaisa, Nadine T.
    Allory, Yves
    Stoehr, Robert
    Wullich, Bernd
    Roupret, Morgan
    Hartmann, Arndt
    Bertz, Simone
    CANCERS, 2020, 12 (03)
12345